MacroGenics Price to Book Ratio 2012-2023 | MGNX
Historical price to book ratio values for MacroGenics (MGNX) over the last 10 years. The current price to book ratio for MacroGenics as of April 22, 2024 is 6.34.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
MacroGenics Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-04-22 | 15.41 | 6.27 | |
2023-12-31 | 9.62 | $2.46 | 3.91 |
2023-09-30 | 4.66 | $3.13 | 1.49 |
2023-06-30 | 5.35 | $2.77 | 1.93 |
2023-03-31 | 7.17 | $1.77 | 4.06 |
2022-12-31 | 6.71 | $2.30 | 2.92 |
2022-09-30 | 3.46 | $2.00 | 1.73 |
2022-06-30 | 2.95 | $2.32 | 1.27 |
2022-03-31 | 8.81 | $2.91 | 3.03 |
2021-12-31 | 16.05 | $3.91 | 4.11 |
2021-09-30 | 20.94 | $4.76 | 4.40 |
2021-06-30 | 26.86 | $5.31 | 5.06 |
2021-03-31 | 31.85 | $5.84 | 5.45 |
2020-12-31 | 22.86 | $5.26 | 4.35 |
2020-09-30 | 25.19 | $5.19 | 4.85 |
2020-06-30 | 27.92 | $4.64 | 6.01 |
2020-03-31 | 5.82 | $3.88 | 1.50 |
2019-12-31 | 10.88 | $4.71 | 2.31 |
2019-09-30 | 12.76 | $5.22 | 2.45 |
2019-06-30 | 16.97 | $6.02 | 2.82 |
2019-03-31 | 17.98 | $6.57 | 2.74 |
2018-12-31 | 12.70 | $5.73 | 2.21 |
2018-09-30 | 21.44 | $6.69 | 3.20 |
2018-06-30 | 20.65 | $7.39 | 2.79 |
2018-03-31 | 25.16 | $6.68 | 3.77 |
2017-12-31 | 19.00 | $8.12 | 2.34 |
2017-09-30 | 18.48 | $5.15 | 3.59 |
2017-06-30 | 17.51 | $6.31 | 2.78 |
2017-03-31 | 18.60 | $6.71 | 2.77 |
2016-12-31 | 20.44 | $7.71 | 2.65 |
2016-09-30 | 29.91 | $8.62 | 3.47 |
2016-06-30 | 26.99 | $9.51 | 2.84 |
2016-03-31 | 18.75 | $8.29 | 2.26 |
2015-12-31 | 30.97 | $9.12 | 3.39 |
2015-09-30 | 21.42 | $9.91 | 2.16 |
2015-03-31 | 31.37 | $7.69 | 4.08 |
2014-12-31 | 35.07 | $4.33 | 8.10 |
2014-09-30 | 20.90 | $5.01 | 4.17 |
2014-06-30 | 21.73 | $5.12 | 4.24 |
2014-03-31 | 27.83 | $5.57 | 4.99 |
2013-12-31 | 27.43 | $3.13 | 8.75 |
2015-06-30 | 37.97 | $7.03 | 5.40 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.977B | $0.059B |
MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
Stryker (SYK) | United States | $123.816B | 30.70 |
Medtronic (MDT) | Ireland | $105.535B | 14.94 |
Boston Scientific (BSX) | United States | $98.780B | 32.84 |
EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
ResMed (RMD) | United States | $26.307B | 26.30 |
Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
Terumo (TRUMY) | Japan | $24.492B | 34.59 |
Baxter (BAX) | United States | $20.044B | 14.62 |
Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
Insulet (PODD) | United States | $11.641B | 61.12 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
Demant (WILYY) | Denmark | $9.965B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
Haemonetics (HAE) | United States | $4.126B | 21.10 |
GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
Envista Holdings (NVST) | United States | $3.430B | 13.05 |
QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
Neogen (NEOG) | United States | $2.515B | 24.19 |
ICU Medical (ICUI) | United States | $2.333B | 17.41 |
TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
Owens & Minor (OMI) | United States | $1.899B | 18.23 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
InMode (INMD) | Israel | $1.462B | 7.57 |
LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
Warby Parker (WRBY) | United States | $1.185B | 0.00 |
AtriCure (ATRC) | United States | $1.122B | 0.00 |
Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.718B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
Evolus (EOLS) | United States | $0.668B | 0.00 |
Quanterix (QTRX) | United States | $0.605B | 0.00 |
Jin Medical (ZJYL) | China | $0.600B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
Valneva SE (VALN) | France | $0.528B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
PetIQ (PETQ) | United States | $0.479B | 17.89 |
ZimVie (ZIMV) | United States | $0.420B | 25.72 |
Biote (BTMD) | United States | $0.413B | 3.93 |
OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
Surmodics (SRDX) | United States | $0.377B | 40.75 |
Zynex (ZYXI) | United States | $0.366B | 42.15 |
Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
Cerus (CERS) | United States | $0.305B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
Veru (VERU) | United States | $0.192B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
High Tide (HITI) | Canada | $0.179B | 0.00 |
Omeros (OMER) | United States | $0.177B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Fonar (FONR) | United States | $0.106B | 9.14 |
MariMed (MRMD) | United States | $0.101B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
Safety Shot (SHOT) | United States | $0.091B | 0.00 |
Brainsway (BWAY) | Israel | $0.081B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
United Health Products (UEEC) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
Bright Green (BGXX) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.039B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 14.30 |
Modular Medical (MODD) | United States | $0.036B | 0.00 |
Exagen (XGN) | United States | $0.024B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
Agape ATP (ATPC) | $0.019B | 0.00 | |
FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |